The JPM executive outlook: New science, yes. Pricing moves, yes. Deal frenzy, no

15th January 2018 Uncategorised 0

As one of our coverage team said as the J.P. Morgan Healthcare Conference was winding down Thursday, this first-of-the-year meeting sets the tone for months to come. And it’s certainly a great place to suss out the general biopharma mood as 2018 begins.

More: The JPM executive outlook: New science, yes. Pricing moves, yes. Deal frenzy, no
Source: fierce